Multi-Agent Portfolio

Digest de scouts: X/opportunity scanner + top holdings 13F + news. Lo consume el consejo (Sentiment/Quant/Fundamental → Risk → PM) en el postmarket.

# MAP Sources Digest — 2026-09-15

_Generated 2026-09-15T20:15:46.209815+00:00_

## 1) Opportunity / X scanner

- Scan: `2026-09-14` · ideas=2 · rejected=19

### Ideas (passed filters)
- **CGEM** — Según el discurso en X, REZILIENT3 reportó mPFS 14.5 vs 8.5 meses, HR 0.50 y ORR 65.0% vs 40.3% para zipalertinib más quimioterapia; el evento refuerza una posible expansión de etiqueta.
- **AVAV** — Según el discurso en X, el backlog financiado habría subido de $1.2B a $1.5B y se menciona un contrato Army para láseres counter-drone LOCUST.

### X discourse — top rejected (still useful signal)
- **ACVA** (0.0% 1d / 49.14% 5d) — Según el discurso en X, Copart acordó adquirir ACV Auctions por $10.50 cash, unos $1.9B de equity value y una prima cercana al 45%.
  - catalysts: Adquisición por Copart, Oferta cash $10.50, Prima ~45%
  - rejected: extended_chase (dist_ma20=37.93%, day=0.0%)
  - risks: Riesgo de cierre, antitrust, plazos y condiciones; la acción queda anclada al precio de oferta.
- **FEIM** (-3.26% 1d / 40.93% 5d) — Según el discurso en X, reportó revenue récord +70% YoY, backlog +82%, book-to-bill 1.76x, márgenes en expansión y flujo de caja positivo.
  - catalysts: Beat de revenue, Backlog +82%, Book-to-bill 1.76x
  - rejected: extended_chase (dist_ma20=30.05%, day=-3.26%)
  - risks: El gap post-resultados puede estar priceado y la extensión aumenta el riesgo de reversión.
- **RH** (0.07% 1d / -9.34% 5d) — Según el discurso en X, RH superó expectativas de revenue y EPS y elevó la guía FY2026 de revenue y margen EBITDA ajustado, con apoyo de RH Estates y tarifas.
  - catalysts: Beat Q2, Guidance FY2026 elevada, RH Estates
  - rejected: structure_breakdown
  - risks: La reacción depende de que se sostenga el crecimiento de lujo y la guía; consumo discrecional sensible al ciclo.
- **SLS** (1.52% 1d / -15.4% 5d) — Según el discurso en X, el ensayo GPS alcanzó el evento preespecificado de la muerte del paciente 80 alrededor del 28 de agosto, pero el resultado todavía no fue difundido.
  - catalysts: GPS Phase 3 AML, Evento de 80 pacientes, Posible topline
  - rejected: structure_breakdown
  - risks: Catalizador binario pendiente, caída fuerte y ruido legal no verificado; alta incertidumbre de disclosure.
- **KYMR** (-0.29% 1d / -2.35% 5d) — Según el discurso en X, el debate se centra en KT-621, su eficacia y seguridad frente a Dupixent, con la valuación reflejando escepticismo antes de resultados Phase 2.
  - catalysts: KT-621 Phase 2, Mercado de dermatitis atópica, Re-rating si valida eficacia
  - rejected: volume_ratio_below_0.8 (0.74)
  - risks: Resultado clínico incierto, competencia, sesgos del trial y presión de pagadores.
- **SMMT** (4.96% 1d / 4.63% 5d) — Según el discurso en X, HARMONi-2 mostró OS de 30.8 vs 22.6 meses y HR 0.73; la lectura es positiva, aunque corresponde a datos de China y no al estudio pivotal global.
  - catalysts: Actualización OS HARMONi-2, OS +8.2 meses, Presentación WCLC
  - rejected: extended_chase (dist_ma20=23.8%, day=4.96%)
  - risks: Datos China-only y volatilidad por short interest; la decisión FDA global sigue siendo binaria.
- **IDYA** (1.17% 1d / -4.59% 5d) — Según el discurso en X, IDEAYA inició un estudio Phase 3 adyuvante de melanoma uveal con Servier para darovasertib y mantiene pipeline clínico activo.
  - catalysts: Inicio Phase 3, Alianza con Servier, Darovasertib
  - rejected: volume_ratio_below_0.8 (0.76)
  - risks: Hitos regulatorios lejanos y riesgo binario de desarrollo clínico.
- **SMR** (-1.16% 1d / -12.27% 5d) — Según el discurso en X, NuScale aparece en el tema de demanda de energía para IA, pero conviven un PT alcista con una caída semanal fuerte y un downgrade de UBS.
  - catalysts: Tema energía para IA, Tecnología SMR, Rebote técnico
  - rejected: structure_breakdown
  - risks: Narrativa especulativa, alta volatilidad y señales de analistas contrapuestas.

## 2) 13F top holdings (latest filing on disk)

### Berkshire — filing 2026-08-14 · 29 names
- APPLE INC: $65.95B (22.04%)
- AMERICAN EXPRESS CO: $51.282B (17.14%)
- COCA COLA CO: $32.508B (10.86%)
- ALPHABET INC: $28.158B (9.41%)
- BANK OF AMER CORP: $27.544B (9.2%)
- CHEVRON CORPORATION: $13.986B (4.67%)
- OCCIDENTAL PETE CORP: $12.868B (4.3%)
- CHUBB LIMITED: $11.67B (3.9%)

### Pershing Square — filing 2026-05-15 · 11 names
- BROOKFIELD CORP: $2.416B (17.62%)
- AMAZON COM INC: $2.385B (17.39%)
- UBER TECHNOLOGIES INC: $2.155B (15.71%)
- MICROSOFT CORP: $2.093B (15.26%)
- RESTAURANT BRANDS INTL INC: $1.674B (12.2%)
- META PLATFORMS INC: $1.522B (11.1%)
- HOWARD HUGHES HOLDINGS INC: $1.193B (8.7%)
- SEAPORT ENTMT GROUP INC: $0.108B (0.79%)

### Scion/Burry — filing 2025-11-03 · 8 names
- PALANTIR TECHNOLOGIES INC: $0.912B (66.04%)
- NVIDIA CORPORATION: $0.187B (13.51%)
- PFIZER INC: $0.153B (11.07%)
- HALLIBURTON CO: $0.061B (4.45%)
- MOLINA HEALTHCARE INC: $0.024B (1.73%)
- LULULEMON ATHLETICA INC: $0.018B (1.29%)
- SLM CORP: $0.013B (0.96%)
- BRUKER CORP: $0.013B (0.95%)

### Appaloosa — filing 2026-08-14 · 27 names
- AMAZON COM INC: $1.192B (15.43%)
- MICRON TECHNOLOGY INC: $1.125B (14.57%)
- TAIWAN SEMICONDUCTOR MANUFAC: $0.788B (10.2%)
- ALPHABET INC: $0.654B (8.46%)
- UBER TECHNOLOGIES INC: $0.555B (7.19%)
- ISHARES INC: $0.49B (6.34%)
- META PLATFORMS INC: $0.38B (4.92%)
- VISTRA CORP: $0.351B (4.55%)

### ARK — filing 2026-08-14 · 191 names
- Tesla Inc: $1.161B (7.54%)
- Advanced Micro Devices Inc: $0.823B (5.34%)
- Space Exploration Technologies Corp: $0.765B (4.97%)
- Tempus AI Inc: $0.581B (3.77%)
- Robinhood Markets Inc: $0.525B (3.41%)
- CRISPR Therapeutics AG: $0.516B (3.35%)
- Shopify Inc: $0.475B (3.08%)
- Twist Bioscience Corp: $0.468B (3.04%)

### Tiger Global — filing 2026-08-14 · 46 names
- TAIWAN SEMICONDUCTOR MANUFAC: $2.331B (9.72%)
- AMAZON COM INC: $2.308B (9.62%)
- NVIDIA CORPORATION: $2.241B (9.34%)
- ALPHABET INC: $2.075B (8.65%)
- META PLATFORMS INC: $1.59B (6.63%)
- LAM RESEARCH CORP: $1.371B (5.72%)
- SEA LTD: $1.204B (5.02%)
- APPLIED MATLS INC: $1.18B (4.92%)

## 3) News (yfinance / map_research)

- SPY $757.39 · 5d -0.66% (H 766.38 / L 756.15)

### MSFT
- Wall Street pushes back on Anthropic's warning as AI spending expected to roll on: Chart of the Day (Yahoo Finance, 2026-09-15)
- Magnificent Seven Stocks Eye Breakout After Sideways 2026 (GuruFocus.com, 2026-09-15)
- Can CRM Stock Justify $260 While Its Cash Engine Cools Off? (Trefis, 2026-09-15)

### GOOGL
- Wall Street pushes back on Anthropic's warning as AI spending expected to roll on: Chart of the Day (Yahoo Finance, 2026-09-15)
- Former Google DeepMind researcher raises a new warning about AI risk (GuruFocus.com, 2026-09-15)
- There Is One Thing ASML’s $400 Million Machine Still Cannot Do. AI Chips Keep Making It Worse. (24/7 Wall St., 2026-09-15)

### AMZN
- Wall Street pushes back on Anthropic's warning as AI spending expected to roll on: Chart of the Day (Yahoo Finance, 2026-09-15)
- Magnificent Seven Stocks Eye Breakout After Sideways 2026 (GuruFocus.com, 2026-09-15)
- Sector Update: Tech Stocks Mixed Late Afternoon (MT Newswires, 2026-09-15)

### JPM
- JPMorgan Chase stock rises after upbeat revenue outlook (Investing.com, 2026-09-15)
- The Forgotten Generation Is Broke: 50% of All New Bankruptcies Are 40-59 Year Olds (24/7 Wall St., 2026-09-15)
- Gold miners still have room to run, says JP Morgan in new sector dashboard (Proactive, 2026-09-15)

### LLY
- Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything (Motley Fool, 2026-09-15)
- Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption (24/7 Wall St., 2026-09-15)
- Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy (Barrons.com, 2026-09-15)

### BRK-B
- Did Greg Abel Already Make His First Big Mistake as Berkshire Hathaway CEO? (Motley Fool, 2026-09-15)
- Warren Buffett Bought Alphabet Stock About a Year Ago. 3 Reasons It’s Still a Buy Today (Motley Fool, 2026-09-15)
- 45% of GameStop’s Sales Now Come From This 1 Business Line (Barchart, 2026-09-15)

### XOM
- Sector Update: Energy Stocks Gain Late Afternoon (MT Newswires, 2026-09-15)
- Sector Update: Energy Stocks Gain Tuesday Afternoon (MT Newswires, 2026-09-15)
- Wood secures $200m contract from ExxonMobil for PNG LNG project (Offshore Technology, 2026-09-15)

### V
- Did Greg Abel Already Make His First Big Mistake as Berkshire Hathaway CEO? (Motley Fool, 2026-09-15)
- Visa Finds Online Spending Gaining Ground Across Key Markets (Zacks, 2026-09-15)
- Walmart slams card fee pact, again (Payments Dive, 2026-09-15)

### ZYME
- JAZZ Rises on Updated OS Results From Gastric Cancer Study (Zacks, 2026-09-01)
- Zymeworks (ZYME), What Is Behind The Renewed Attention? (Simply Wall St., 2026-08-28)
- Is Zymeworks (ZYME) Stock Fully Priced After Its 301% Run? (Simply Wall St., 2026-08-28)

### SPY
- QuantumScape Is Down 51% This Year. Is QS Stock Dead Money or Due for a Bounce? (24/7 Wall St., 2026-09-15)
- Klarna Is Down 51% This Year. Is KLAR Stock Dead Money or Due for a Bounce? (24/7 Wall St., 2026-09-15)
- Sirius XM Stock Is Up 53% in 2026: Take Profits, or Buy More? (24/7 Wall St., 2026-09-15)

## Cómo usar esto (Bull / Bear / PM)

- Bull: priorizá catalysts de la sección X + news alineados a momentum USA.
- Bear: usá reasons_rejected + risks + concentración 13F como veto/overcrowding.
- PM: no copies 13F ciegamente; es contexto, no orden.